Ex Parte Donoho et al - Page 14


                 Appeal No. 2003-1794                                                       Page 14                    
                 Application No. 09/804,969                                                                            

                        We do not agree with Appellants that the claimed polynucleotides have                          
                 utility because the encoded protein has been identified as a putative                                 
                 phospholipase.  All that Appellants’ specification discloses regarding the                            
                 polypeptide of SEQ ID NO:15 is that it has some unspecified degree of sequence                        
                 similarity to “animal phospholipases, including phospholipase C delta-4.”  Page 2.                    
                 No further information is provided regarding the activity or function of either the                   
                 polypeptide encoded by the claimed polynucleotides or the phospholipase C                             
                 delta-4 with which it has some unspecified degree of sequence similarity.                             
                        As the examiner pointed out, phospholipases have different biological                          
                 roles.  The evidence of record supports the examiner’s position, and shows that                       
                 phospholipases have widely varying activities in vivo.  See, e.g., the instant                        
                 specification, which discloses that “[p]hospholipases . . . can play a key role in                    
                 the cell activation and signal transduction.  As such, phospholipases have been                       
                 associated with, inter alia, development, inflammation, infectious disease, and                       
                 cancer.”  Page 1.  See also the abstracts submitted with the Appeal Brief                             
                 (Exhibits D through H).  These abstracts show that                                                    
                        • there are at least four isozymes of the delta type of phospholipase C                        
                          (PLC), and there exist “pathological conditions in which an abnormal                         
                          protein level of PLC delta or its activity have been observed” (Pawelczyk,                   
                          Exhibit D);                                                                                  
                        • different isozymes of phospholipase C play a role in development of the                      
                          rat central nervous system (Shimohama et al., Exhibit E); development                        
                          of the cerebellum (Hashimoto et al., Exhibit E); renal development and                       
                          hematopoiesis (Shirane et al., Exhibit E); and B-cell function and                           
                          development (Kurosaki et al., Exhibit E); and phospholipase D1 plays a                       
                          role in development of the retina (Lee et al., Exhibit E);                                   
                        • expression of one isozyme of phospholipase C is induced by growth                            
                          factors (Fukami et al., Exhibit F), and expression of another isozyme is                     






Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007